Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/MRI with 18F-DCFPyL for Prostate Cancer Staging
NCT03392181Phase 1Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Jun 2018
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Northwestern University. Primary endpoint: PET/MR versus mp-MRI for the Staging of Newly Diagnosed Prostate Cancer at 5 years. Started Jun 2018; status: active, not recruiting.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03392181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03392181.